Xeris Biopharma Holdings, Inc.
XERS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867096
In the last 90 days, Xeris Biopharma Holdings, Inc. insiders filed 0 open-market purchases and 11 sales; 242 institutions reported holding it in 13F filings for Q2 2026, worth $857.1M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Xeris Biopharma Holdings, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 94 | 71 | −23 |
| Shares | 28.2M | 17.5M | −10.6M (−37.8%) |
| Value | $114.9M | $42.9M | −$71.9M (−62.6%) |
New holders (9)
Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Man Group plc | 36,400 | $89.0K | 0.00% |
| 683 Capital Management, LLC | 30,000 | $74.0K | 0.00% |
| Rafferty Asset Management, LLC | 29,167 | $71.0K | 0.00% |
| Searle & Co. | 20,000 | $49.0K | 0.02% |
| Apollon Wealth Management, LLC | 20,160 | $49.0K | 0.01% |
| HSBC Holdings PLC | 15,219 | $37.0K | 0.00% |
| O'Dell Group, LLC | 584 | $1.00K | 0.00% |
| Northwestern Mutual Wealth Management Co | 100 | $0 | 0.00% |
| Meridian Wealth Partners, LLC | 170 | $0 | 0.00% |
Sold out (32)
Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.